Funding Rounds
Datavault AI Raises $60 Million to Deploy Quantum-Ready GPU Edge Network
Datavault AI Inc. closed a $60 million registered direct offering, with proceeds earmarked for deploying its quantum-ready GPU edge network and general corporate purposes.
Wearable Devices Ltd. Secures $5 Million Through Warrant Exercise Agreement
Wearable Devices Ltd. has secured approximately $5 million in funding through a warrant inducement agreement with an existing institutional investor, providing capital for the AI-powered touchless sensing technology company's working capital and general corporate purposes.
UNLOCKD Inc. Advances Strategic Partnerships, Funding, and Digital Asset Integration
UNLOCKD Inc. is nearing completion of a strategic brand partnership and equity funding round while implementing digital asset initiatives that could reshape corporate treasury management and investor participation in public companies.
Cybin Secures $175 Million in Funding to Advance Mental Health Therapeutics
Cybin Inc. has closed a $175 million registered direct offering with top healthcare investors, providing critical capital to advance its Phase 3 clinical programs for novel mental health treatments addressing major depressive disorder and generalized anxiety disorder.
Duquesne Family Office Backs Q.ANT's Photonic AI Processors in Record European Funding Round
Q.ANT secured $80 million in Series A funding to commercialize energy-efficient photonic processors that could transform AI infrastructure by delivering up to 30x greater energy efficiency and 50x performance gains.
Quantum BioPharma Licensee Unbuzzd Wellness Announces Investor Webinar for $5 Million Funding Round
Unbuzzd Wellness, a licensee of Quantum BioPharma, is hosting an investor webinar to raise up to $5 million for its scientifically proven alcohol metabolism beverage, representing a strategic non-dilutive funding opportunity for Quantum shareholders.
Humacyte Secures $60 Million in Oversubscribed Stock Offering to Advance Bioengineered Tissue Platform
Humacyte's successful $60 million capital raise provides critical funding to accelerate development of its universally implantable bioengineered human tissues, which have received multiple FDA designations and could transform treatment for vascular trauma, dialysis access, and other medical conditions.
Lexaria Bioscience Secures $4 Million in Capital to Advance 2026 Research and Development Initiatives
Lexaria Bioscience Corp. has completed a $4 million registered direct offering, providing crucial funding to advance its 2026 R&D and business development plans for its DehydraTECH drug delivery technology.
AtlasClear Holdings Completes $5 Million Funding Round with Strong Board Member Participation
AtlasClear Holdings has secured $5 million in financing primarily from its own board members, signaling strong internal confidence in the company's fintech strategy to bridge traditional finance with emerging financial products.
Padel 100 Secures €5 Million Investment to Build 300 Courts Across Ireland by 2027
Ireland's fastest-growing padel operator Padel 100 has launched a €5 million funding round through the Employment Investment Incentive Scheme to install 300 courts nationwide, positioning Ireland among Europe's emerging padel markets.
Brera Holdings Rebrands as Solmate Following $300 Million PIPE Led by Pulsar Group
Brera Holdings PLC is rebranding as Solmate after securing $300 million in funding to focus on Solana-based digital asset infrastructure, signaling a major strategic pivot from sports to blockchain technology.
XTI Aerospace Prices $20 Million Public Offering to Fund TriFan 600 Development
XTI Aerospace's $20 million public offering will accelerate development of its innovative TriFan 600 vertical takeoff aircraft and support its real-time location systems technology business.
Phlow Corp. Secures $37 Million in Series C Funding to Enhance U.S. Pharmaceutical Supply Chain
Phlow Corp.'s recent $37 million Series C funding round, led by Align Private Capital, underscores its commitment to addressing critical shortages in essential medicines and advancing U.S.-based pharmaceutical manufacturing.
Sekur Private Data Ltd. Launches CA$2 Million Private Placement to Fuel Global Expansion
Sekur Private Data Ltd. announces a CA$2 million private placement to accelerate its global marketing efforts and strengthen its position in the cybersecurity and privacy communications sector.
Catalio Capital Invests in $130 Million Series B Funding for GlycoEra to Advance Autoimmune Disease Treatments
Catalio Capital Management has participated in a $130 million Series B funding round for GlycoEra AG, a Swiss biotech firm, to develop innovative treatments for autoimmune diseases, marking a significant step forward in life sciences investment and healthcare innovation.
FAVO Capital Secures $8 Million Series A Investment to Accelerate SMB Funding and Nasdaq Listing
FAVO Capital, a private credit platform specializing in revenue-based funding for small and medium-sized businesses, has received $8 million in Series A investment from Stewards Investment Capital, positioning the company for strategic growth and potential Nasdaq uplisting.
AST SpaceMobile Secures $460 Million, Aims to Revolutionize Global Cellular Connectivity
AST SpaceMobile has raised significant financing to develop the world's first space-based cellular broadband network, potentially bridging connectivity gaps for billions of unserved mobile users worldwide.
Image Protect Undergoes Strategic Leadership Change with MJW Capital Funding Acquisition
Image Protect announces a significant change in control as MJW Capital Funding LLC acquires all Series A Preferred shares, bringing new leadership and potential funding to strengthen its position in online reputation management and text marketing services.